Adverum Biotechnologies Receives Fast Track Designation for ADVM-022 Gene Therapy for the Treatment of wAMD Read more
Fasenra shows consistent safety and sustained efficacy in long-term Phase III BORA trial in severe eosinophilic asthma Read more
Just Biotherapeutics Announces Product Development and Manufacturing Agreement with Pandion Therapeutics Read more
Roivant Launches Respivant Sciences to Develop Innovative Therapeutics for Respiratory Diseases Read more
Evotec and Almirall enter into research collaboration in the field of dermatological diseases Read more
Halozyme Announces Approval Of Subcutaneous Formulation Of Trastuzumab (Herceptin) In Canada Read more